Brief: Akari Therapeutics Releases CEO Corner Segment With CEO Abizer Gaslightwala
Jan 9 (Reuters) - Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS PLC - RELEASES CEO CORNER SEGMENT WITH CEO ABIZER GASLIGHTWALA Source text: ID:nGNX2kDdRG Further company coverage: AKTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics